FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283275594> ?p ?o ?g. }

• W4283275594 endingPage "840" @default.
• W4283275594 startingPage "837" @default.
• W4283275594 abstract "STXBP1 encodes syntaxin-binding protein 1, a brain-expressed membrane trafficking protein that facilitates presynaptic vesicle docking in neurotransmission. Heterozygous loss-of-function variants were originally associated with infantile developmental and epileptic encephalopathy (DEE4, OMIM #612164),1 with the phenotype later expanding to include a wide range of severe epilepsies, intellectual disability, and other neurodevelopmental disorders.2 Movement disorders including ataxia, tremor, dyskinesia, dystonia, bruxism and stereotypies have been described, though nearly always accompanied by epilepsy and intellectual disability.2 We report a child with an STXBP1 stop-loss variant, who presented with an infantile onset complex movement disorder without epilepsy and only mild cognitive difficulties. Now adopted, he was born to non-consanguineous parents. His birth parents both have a history of epilepsy and learning difficulties; in addition, his father has dystonia and tremor, and paternal grandmother had dystonia. His older biological sister has learning difficulties, joint hypermobility and attention deficit hyperactivity disorder (ADHD) but no movement disorder or epilepsy. Following a normal pregnancy and birth, tremor was evident from 6 weeks of age, rhythmic rocking movements from 6 months, and his development was delayed; he walked independently at 4 years and first words were noted from 2 years of age. He has writing difficulties and frequent falls which cause injury. His tremor is worsened by anxiety, fatigue or heightened emotion and later in the day his posture becomes crouched. His sleep pattern is disrupted with lower limb night cramps. He attends a mainstream school where he has extra support including speech and language therapy. He has additional diagnoses of ADHD, autistic spectrum disorder and hypermobile Ehlers-Danlos syndrome. Trials of Levodopa, Trihexyphenidyl and Levetiracetam had no perceived benefit and were discontinued. Melatonin has been effective in improving sleep. Examination at age 9 years revealed marked action-induced tremor of both arms and hands and intermittent dystonic finger posturing, tremulous tongue movements and difficulty on tandem walking (Video 1). Using established methods,3 whole genome sequencing using a broad neurology panel of 3447 genes revealed a novel heterozygous stop-loss variant in STXBP1 [NM_001032221.6] c.1783 T > C, p.(*595Glnext*67), predicting abolition of the stop codon and addition of 67 amino acid residues at the C-terminus. The variant, confirmed by Sanger sequencing, is absent from gnomAD. Segregation studies were not possible due to familial estrangement. No other pathogenic variants were identified. MRI brain and spine scans age 1, 3, and 5 years showed only mild hypomyelination at 3 years. Prior genetic testing for microarray CGH, fragile X single-gene testing, and clinical exome analysis of panels for ataxia, dystonia and hyperkinesia were negative (N.B. STXBP1 was not included in these gene panels), and neurometabolic investigations on blood, urine, and CSF were non-diagnostic (Supplementary Information). EEG showed no epileptiform discharges. Experimental animal models including expression of human disease variants in mice suggest that STXBP1-encephalopathy is related to haploinsufficiency rather than a dominant-negative mechanism.4 Stop-loss mutations are an infrequent but recognized mechanism of genetic disease, not previously reported in STXBP1.5 The downstream consequences of the stop-loss variant are unclear, but may include putative loss-of-function effects impacting protein folding, subcellular location or substrate binding due to protein elongation. We propose this variant as the likely cause of disease in this patient due to phenotypic overlap, lack of alternative cause on detailed genetic analysis, and haploinsufficiency intolerance of the gene. However, population databases indicate that stop-loss changes are less selected against than other nonsense variants.6 Segregation analysis was not possible, but given the expanding spectrum of STXBP1-related disease, it can be speculated that one of the proband's parents may also harbor this same variant, which may explain some or all of their difficulties. Although STXBP1-related disorder is strongly associated with epilepsy (95%) and severe/profound intellectual disability (88%),2, 7 our case had no history of seizures and only mild cognitive difficulties. To date, movement disorders without epilepsy are only rarely reported in STXBP1-related disease and all described cases have severe ID: 3 girls with ataxia and tremor8; one individual with spasticity and tremor9; and one with tremor with myoclonus10 (Table 1). A recent description bringing together 534 cases of STXBP1-related disorders using Human Phenotype Ontology terms has revealed a broader phenotype; ataxia and tremor are common (25% and 24% of cohort respectively) and seizures are described in 89%, but the combined lack of epilepsy or severe learning difficulties remains rare.5 Our case expands the proposed genotype of STXBP1-related disease and illustrates the emerging milder phenotype without epilepsy or significant intellectual disability; it also highlights the importance of including STXBP1 in movement disorder gene panels for diagnostic next-generation sequencing analysis. GDD from 6m walked at 3y GDD from 4m walked at 3.5y GDD from 7m walked at 2.5y GDD walked at 2y GDD regression walks though unsteady limited speech We thank the family for participation in this study and for permission to publish this letter. (1) Research project: A. Conception, B. Organization, C. Execution; (2) Data Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript Preparation: A. Writing of the first draft, B. Review and Critique. All authors contributed to the writing of this letter and reviewed the final version. RS: 1B, 1C, 2C, 3A, 3B DS: 1B, 1C, 2B, 3B KB: 1B, 1C, 2B, 3B PP: 2B, 3B EW: 2B, 3B MK: 1A, 1B, 1C, 2A, 2C, 3B The authors declare they have no conflict of interest relating to this manuscript. This study was funded by an NIHR Professorship (MAK, DS, RS), The Sir Jules Thorn Biomedical Award for Research (MAK, KB) and Rosetrees Trust (MAK, KB). The views expressed are those of the authors and not necessarily those of the NIHR. RS's salary is supported by grants from the NIHR, Great Ormond Hospital Children's Charity, and LifeArc; DS's salary is supported by grant from the NIHR; KB's salary is supported by grant from the NIHR, with research supported by grants from NIHR, Sir Jules Thorne and Rosetrees trust; MAK's salary is supported by grant from the NIHR, with research supported by grants from NIHR, Sir Jules Thorne, Rosetrees trust, Great Ormond Hospital Children's Charity, and LifeArc; PP and EW have nothing to disclose. The study was approved by the National Research Ethics Service in the United Kingdom (National Research Ethics Service Committee: London-Bloomsbury, REC reference: 13/LO/0168), and performed in accordance with the Declaration of Helsinki. The family have provided written consent for analysis and publication, including the acquisition, editing and publication of the video. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Appendix S1 Supplementary information. Includes details of the non-diagnostic investigations. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article." @default.
• W4283275594 created "2022-06-23" @default.
• W4283275594 creator A5003519413 @default.
• W4283275594 creator A5011986585 @default.
• W4283275594 creator A5017916851 @default.
• W4283275594 creator A5020064048 @default.
• W4283275594 creator A5078129125 @default.
• W4283275594 creator A5090101949 @default.
• W4283275594 date "2022-07-23" @default.
• W4283275594 modified "2023-09-27" @default.
• W4283275594 title "<scp><i>STXBP1</i></scp> Stop‐Loss Mutation Associated with Complex Early Onset Movement Disorder without Epilepsy" @default.
• W4283275594 cites W2073032316 @default.
• W4283275594 cites W2170441848 @default.
• W4283275594 cites W2256016639 @default.
• W4283275594 cites W2296516270 @default.
• W4283275594 cites W2343935798 @default.
• W4283275594 cites W2791913816 @default.
• W4283275594 cites W3081268598 @default.
• W4283275594 cites W3113097269 @default.
• W4283275594 cites W3181830020 @default.
• W4283275594 cites W4206071515 @default.
• W4283275594 doi "https://doi.org/10.1002/mdc3.13509" @default.
• W4283275594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35937496" @default.
• W4283275594 hasPublicationYear "2022" @default.
• W4283275594 type Work @default.
• W4283275594 citedByCount "1" @default.
• W4283275594 countsByYear W42832755942022 @default.
• W4283275594 crossrefType "journal-article" @default.
• W4283275594 hasAuthorship W4283275594A5003519413 @default.
• W4283275594 hasAuthorship W4283275594A5011986585 @default.
• W4283275594 hasAuthorship W4283275594A5017916851 @default.
• W4283275594 hasAuthorship W4283275594A5020064048 @default.
• W4283275594 hasAuthorship W4283275594A5078129125 @default.
• W4283275594 hasAuthorship W4283275594A5090101949 @default.
• W4283275594 hasBestOaLocation W42832755941 @default.
• W4283275594 hasConcept C104317684 @default.
• W4283275594 hasConcept C118552586 @default.
• W4283275594 hasConcept C126322002 @default.
• W4283275594 hasConcept C15744967 @default.
• W4283275594 hasConcept C169760540 @default.
• W4283275594 hasConcept C2778186239 @default.
• W4283275594 hasConcept C2778261627 @default.
• W4283275594 hasConcept C2779134260 @default.
• W4283275594 hasConcept C501734568 @default.
• W4283275594 hasConcept C54355233 @default.
• W4283275594 hasConcept C71924100 @default.
• W4283275594 hasConcept C86803240 @default.
• W4283275594 hasConceptScore W4283275594C104317684 @default.
• W4283275594 hasConceptScore W4283275594C118552586 @default.
• W4283275594 hasConceptScore W4283275594C126322002 @default.
• W4283275594 hasConceptScore W4283275594C15744967 @default.
• W4283275594 hasConceptScore W4283275594C169760540 @default.
• W4283275594 hasConceptScore W4283275594C2778186239 @default.
• W4283275594 hasConceptScore W4283275594C2778261627 @default.
• W4283275594 hasConceptScore W4283275594C2779134260 @default.
• W4283275594 hasConceptScore W4283275594C501734568 @default.
• W4283275594 hasConceptScore W4283275594C54355233 @default.
• W4283275594 hasConceptScore W4283275594C71924100 @default.
• W4283275594 hasConceptScore W4283275594C86803240 @default.
• W4283275594 hasFunder F4320320000 @default.
• W4283275594 hasFunder F4320320320 @default.
• W4283275594 hasFunder F4320335255 @default.
• W4283275594 hasIssue "6" @default.
• W4283275594 hasLocation W42832755941 @default.
• W4283275594 hasLocation W42832755942 @default.
• W4283275594 hasLocation W42832755943 @default.
• W4283275594 hasLocation W42832755944 @default.
• W4283275594 hasLocation W42832755945 @default.
• W4283275594 hasOpenAccess W4283275594 @default.
• W4283275594 hasPrimaryLocation W42832755941 @default.
• W4283275594 hasRelatedWork W1975440733 @default.
• W4283275594 hasRelatedWork W2060279210 @default.
• W4283275594 hasRelatedWork W2063228636 @default.
• W4283275594 hasRelatedWork W2166907382 @default.
• W4283275594 hasRelatedWork W2748952813 @default.
• W4283275594 hasRelatedWork W2766309205 @default.
• W4283275594 hasRelatedWork W2789661527 @default.
• W4283275594 hasRelatedWork W2899084033 @default.
• W4283275594 hasRelatedWork W2916001803 @default.
• W4283275594 hasRelatedWork W3185675323 @default.
• W4283275594 hasVolume "9" @default.
• W4283275594 isParatext "false" @default.
• W4283275594 isRetracted "false" @default.
• W4283275594 workType "article" @default.